Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31.0Revenue $M2.2Net Margin (%)-832.1Altman Z-Score-13.0
Enterprise Value $M23.8EPS $-0.3Operating Margin %-846.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)-832.1Higher ROA y-yN
Price/Book6.010-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsY
Price/Sales10.75-y EBITDA Growth Rate %--Current Ratio3.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-180.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-382.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NBY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NBY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NBY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Najafi RaminCEO, 10% Owner 2015-08-20Buy12,000$0.47-10.64view
Pioneer Pharma (Singapore) Pte10% Owner 2015-03-03Buy2,590,000$0.6-30view
SIECZKAREK MARK MDirector 2015-03-03Buy166,666$0.6-30view
Najafi RaminChairman 2015-03-03Buy166,666$0.6-30view
Najafi RaminChairman 2014-12-12Buy50,000$0.65-35.38view
PAULSON THOMAS JCFO 2014-12-12Buy10,000$0.68-38.24view
Stroman David W.SVP, Ophthalmic Product Devt. 2014-12-12Buy10,000$0.66-36.36view
Najafi RaminChairman 2014-12-11Buy20,000$0.6-30view
PAULSON THOMAS JCFO 2014-12-09Buy10,000$0.67-37.31view
Najafi RaminChairman 2014-12-05Buy25,000$0.65-35.38view

Press Releases about NBY :

Quarterly/Annual Reports about NBY:

    News about NBY:

    Articles On GuruFocus.com
    Novabay Pharmaceuticals' CEO Dr. Ramin Najafi Interviewed by The Life Sciences Report Jun 25 2015 
    Own it Feb 29 2012 
    NovaBay Pharmaceuticals Inc. (NBY) Chairman Ramin Najafi buys 1,000 Shares Aug 28 2009 
    NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results Aug 14 2009 

    More From Other Websites
    NovaBay Pharmaceuticals to Present at Rodman & Renshaw Global Investment Conference Sep 03 2015
    NovaBay Pharmaceuticals to Present at Rodman & Renshaw Global Investment Conference Sep 03 2015
    NovaBay Pharmaceuticals Signs Distribution Agreement to Make Avenova Available in New Zealand Sep 02 2015
    NovaBay Pharmaceuticals Signs Distribution Agreement to Make Avenova Available in New Zealand Sep 02 2015
    NovaBay Pharmaceuticals Signs Distribution Agreement to Make Avenova Available in New Zealand Sep 02 2015
    NOVABAY PHARMACEUTICALS, INC. Financials Aug 27 2015
    Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face Aug 27 2015
    NovaBay Pharmaceuticals’ intelli-Case Featured on ABC Television Aug 24 2015
    NovaBay Pharmaceuticals’ intelli-Case Featured on ABC Television Aug 24 2015
    Keeping Eyes Healthy with Daily Hygiene at North Shore Eye Aug 19 2015
    NovaBay Pharmaceuticals Reports 2015 Second Quarter Financial Results Aug 16 2015
    10-Q for NovaBay Pharmaceuticals, Inc. Aug 15 2015
    China Pioneer Pharma Offers Free NeutroPhase to Victims Suffered Burns in the Explosion in Tianjin Aug 14 2015
    NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 13 2015
    NovaBay Pharmaceuticals Reports 2015 Second Quarter Financial Results Aug 13 2015
    Q2 2015 NovaBay Pharmaceuticals Inc Earnings Release - After Market Close Aug 13 2015
    NovaBay Pharmaceuticals to Hold Second Quarter 2015 Conference Call on August 13 Jul 30 2015
    NovaBay Pharmaceuticals to Hold Second Quarter 2015 Conference Call on August 13 Jul 30 2015
    NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jul 16 2015
    NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE Jul 16 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK